Your search for "Ceva acquires Sogeval" return 20 results.
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Ceva Santé Animale confirms its circle of virtuous growth in 2016 >
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
Ceva Biomune Breaks Ground on $20MM Expansion in Lenexa >
Ceva Biomune has broken ground on a new facility to meet demand for its vaccine products.
Van Buskirk to serve as Director, Ceva Business Solutions >
Ceva Animal Health has promoted Mark Van Buskirk to the role of Director, Ceva Business Solutions.
Ceva Animal Health posts strong double-digit growth again in 2014 >
Sales grew in all zones and across all species
Ceva Animal Health completes integration of Sogeval Animal Health >
Ceva Animal Health’s integration of Sogeval Laboratories is strengthening the company’s ability to provide total pet health solutions to veterinarians and their clients.
Ceva Animal Health Acquires Sogeval >
Ceva Animal Health has acquired Sogeval, a subsidiary of Sofiprotéol, solidifying Ceva’s position as a Top 10 global animal health company.
Ceva in exclusive merger negotiations with Sogeval >
French veterinary pharmaceutical companies Ceva Santé Animale (Ceva), based in Libourne, and Sogeval (a subsidiary of Sofiprotéol), based in Laval have entered into exclusive merger negotiations.
Ceva Sales Force Named Top Poultry Sales Team >
Ceva’s US force has been recognized as the top sales team in the poultry vaccine industry by C.F. Grass Consulting, a premier provider of marketing research and advice in the animal health market.
Ceva Animal Health Introduces Vectormune® HVT-LT >
Vector vaccine protects agains both Infectious Laryngotracheitis and Marek's disease